Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$1.7B
Avg Funding
$69.4M
Global Reach
6
countries

Top Cities for Therapeutics

Boston
San Diego
South San Francisco
Charlottesville
Palo Alto
Hanover

Recently Funded Companies

Export
Boston, United States

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

$225.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

$66.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.

$275.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Charlottesville, United States

Navion Neurosciences is a pre-clinical stage biotechnology company that develops sodium channel therapeutics for neurological diseases.

$10.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Ridge Biotechnologies is an AI-driven biotechnology company that designs precision enzymes, linkers, and targeted therapeutics.

$13.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Hanover, Germany

Allogenetics provides a unique solution to the problem of organ rejection following transplantation.

$4.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

General Cybernetics is a company that offers technology driven products and services.

$15.3M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

DynamiCare Health is a digital platform helping people monitor and reduce the use of drugs, opioids, alcohol, and tobacco.

$720K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.

$1.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

$380.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.

$116.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

$400.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.

$5.1M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Tsukuba, Japan

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

$7.9M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Flip Therapeutics develops in vivo immune cell reprogramming therapies for chronic autoimmune and inflammatory diseases.

$676K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.

$56.3M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Laguna Niguel, United States

RNAV8 Bio is a stealth-mode company that focuses on engineering and designing large RNAs to treat chronic and acute, pre-cancerous diseases.

$4.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Andover, United States

Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.

$1.8M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

$400K raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Deliverome Bio builds an open atlas of human surface proteins for targeted delivery research.

$5.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Phoenixville, United States

PleoPharma is a pharmaceutical company that focuses on finding treatments for cannabis related health issues.

$6.5M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States

KaliVir Immunotherapeutics develops oncolytic viral immunotherapy programs for the treatment of cancer.

$14.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Suisse, France

Bewelab is the first neuroscience-based digital intervention targeting cravings at the neural level.

$2.5M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Worcester, United States

Leal Therapeutics develops novel therapeutics for patients.

$30.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

$92.7M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$69.4M
Total Funding Tracked
$1.7B
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Cambridge
4 companies$461.7M
2.Boston
3 companies$241.0M
3.San Diego
1 companies$66.0M
4.South San Francisco
1 companies$275.0M
5.Charlottesville
1 companies$10.8M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked